These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 16412628

  • 1. Development of a disease-specific Quality of Life questionnaire module for patients with gastrointestinal neuroendocrine tumours.
    Davies AH, Larsson G, Ardill J, Friend E, Jones L, Falconi M, Bettini R, Koller M, Sezer O, Fleissner C, Taal B, Blazeby JM, Ramage JK, EORTC Quality of Life Group.
    Eur J Cancer; 2006 Mar; 42(4):477-84. PubMed ID: 16412628
    [Abstract] [Full Text] [Related]

  • 2. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation.
    Velikova G, Weis J, Hjermstad MJ, Kopp M, Morris P, Watson M, Sezer O, EORTC Quality of Life Group.
    Eur J Cancer; 2007 Jan; 43(1):87-94. PubMed ID: 17081744
    [Abstract] [Full Text] [Related]

  • 3. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18.
    Blazeby JM, Currie E, Zee BC, Chie WC, Poon RT, Garden OJ, EORTC Quality of Life Group.
    Eur J Cancer; 2004 Nov; 40(16):2439-44. PubMed ID: 15519517
    [Abstract] [Full Text] [Related]

  • 4. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
    Greimel ER, Kuljanic Vlasic K, Waldenstrom AC, Duric VM, Jensen PT, Singer S, Chie W, Nordin A, Bjelic Radisic V, Wydra D, European Organization for Research and Treatment of Cancer Quality-of-Life Group.
    Cancer; 2006 Oct 15; 107(8):1812-22. PubMed ID: 16977652
    [Abstract] [Full Text] [Related]

  • 5. Development of a European organization for research and treatment of cancer module to assess the quality of life of patients with proctitis after pelvic radiotherapy for malignancy.
    Spry N, Halkett G, Aoun S, Spry J, Yeoh E.
    Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):522-8. PubMed ID: 18374505
    [Abstract] [Full Text] [Related]

  • 6. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach.
    Lagergren P, Fayers P, Conroy T, Stein HJ, Sezer O, Hardwick R, Hammerlid E, Bottomley A, Van Cutsem E, Blazeby JM, European Organisation for Research Treatment of Cancer Gastrointestinal and Quality of Life Groups.
    Eur J Cancer; 2007 Sep 01; 43(14):2066-73. PubMed ID: 17702567
    [Abstract] [Full Text] [Related]

  • 7. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU.
    Oncology; 2008 Sep 01; 74 Suppl 1():7-12. PubMed ID: 18758191
    [Abstract] [Full Text] [Related]

  • 8. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
    Blazeby JM, Conroy T, Bottomley A, Vickery C, Arraras J, Sezer O, Moore J, Koller M, Turhal NS, Stuart R, Van Cutsem E, D'haese S, Coens C, European Organisation for Research and Treatment of Cancer Gastrointestinal and Quality of Life Groups.
    Eur J Cancer; 2004 Oct 01; 40(15):2260-8. PubMed ID: 15454251
    [Abstract] [Full Text] [Related]

  • 9. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
    Hjermstad MJ, Bergenmar M, Fisher SE, Montel S, Nicolatou-Galitis O, Raber-Durlacher J, Singer S, Verdonck-de Leeuw I, Weis J, Yarom N, Herlofson BB.
    Eur J Cancer; 2012 Sep 01; 48(14):2203-11. PubMed ID: 22572480
    [Abstract] [Full Text] [Related]

  • 10. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma.
    Cocks K, Cohen D, Wisløff F, Sezer O, Lee S, Hippe E, Gimsing P, Turesson I, Hajek R, Smith A, Graham L, Phillips A, Stead M, Velikova G, Brown J, EORTC Quality of Life Group.
    Eur J Cancer; 2007 Jul 01; 43(11):1670-8. PubMed ID: 17574838
    [Abstract] [Full Text] [Related]

  • 11. The EORTC ophthalmic oncology quality of life questionnaire module (EORTC QLQ-OPT30). Development and pre-testing (Phase I-III).
    Brandberg Y, Damato B, Kivelä T, Kock E, Seregard S, EORTC Ophthalmic Oncology Task Force, EORTC Quality of Life Group.
    Eye (Lond); 2004 Mar 01; 18(3):283-9. PubMed ID: 15004578
    [Abstract] [Full Text] [Related]

  • 12. [Quality of life assessment in pancreatic carcinoma: results of an European multicentric study].
    Bassi C, Johnson C, Fitzsimmons D, Falconi M, Butturini G, Contro C, Frigerio I, Pederzoli P.
    Chir Ital; 1999 Mar 01; 51(5):359-66. PubMed ID: 10738609
    [Abstract] [Full Text] [Related]

  • 13. Understanding the EORTC QLQ-BM22, the module for patients with bone metastases.
    Chow E, Bottomley A.
    Expert Rev Pharmacoecon Outcomes Res; 2009 Oct 01; 9(5):461-5. PubMed ID: 19817529
    [Abstract] [Full Text] [Related]

  • 14. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20.
    Postma TJ, Aaronson NK, Heimans JJ, Muller MJ, Hildebrand JG, Delattre JY, Hoang-Xuan K, Lantéri-Minet M, Grant R, Huddart R, Moynihan C, Maher J, Lucey R, EORTC Quality of Life Group.
    Eur J Cancer; 2005 May 01; 41(8):1135-9. PubMed ID: 15911236
    [Abstract] [Full Text] [Related]

  • 15. Validation of EORTC quality-of-life questionnaire in Indian women with operable breast cancer.
    Parmar V, Badwe RA, Hawaldar R, Rayabhattanavar S, Varghese A, Sharma R, Mittra I.
    Natl Med J India; 2005 May 01; 18(4):172-7. PubMed ID: 16252544
    [Abstract] [Full Text] [Related]

  • 16. [An improved quality of life self-questionnaires specific for head and neck tumors].
    Schraub S, Mercier M, Eschwège F, Lefebvre JL, Vrousos C, Barthod L.
    Rev Epidemiol Sante Publique; 1996 Aug 01; 44(4):346-57. PubMed ID: 8927777
    [Abstract] [Full Text] [Related]

  • 17. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer.
    Oñate-Ocaña LF, Alcántara-Pilar A, Vilar-Compte D, García-Hubard G, Rojas-Castillo E, Alvarado-Aguilar S, Carrillo JF, Blazeby JM, Aiello-Crocifoglio V.
    Ann Surg Oncol; 2009 Jan 01; 16(1):88-95. PubMed ID: 18979141
    [Abstract] [Full Text] [Related]

  • 18. Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24).
    Greimel E, Nordin A, Lanceley A, Creutzberg CL, van de Poll-Franse LV, Radisic VB, Galalae R, Schmalz C, Barlow E, Jensen PT, Waldenström AC, Bergmark K, Chie WC, Kuljanic K, Costantini A, Singer S, Koensgen D, Menon U, Daghofer F, EORTC Quality of Life Group.
    Eur J Cancer; 2011 Jan 01; 47(2):183-90. PubMed ID: 20851597
    [Abstract] [Full Text] [Related]

  • 19. Development of an EORTC module to improve quality of life assessment in patients with gastric cancer.
    Vickery CW, Blazeby JM, Conroy T, Johnson CD, Alderson D.
    Br J Surg; 2000 Mar 01; 87(3):362-73. PubMed ID: 10718972
    [Abstract] [Full Text] [Related]

  • 20. Patient preference for either the EORTC QLQ-C30 or the FACIT Quality Of Life (QOL) measures: a study performed in patients suffering from carcinoma of an unknown primary site (CUP).
    Rodary C, Pezet-Langevin V, Garcia-Acosta S, Lesimple T, Lortholary A, Kaminsky MC, Bennouna J, Culine S, Bourgeois H, Fizazi K.
    Eur J Cancer; 2004 Mar 01; 40(4):521-8. PubMed ID: 14962718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.